Stay updated on Nivolumab in Malignant Pleural Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page.

Latest updates to the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision updated to v3.4.1 from v3.4.0; no changes to core study content, eligibility criteria, outcomes, or locations observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page now shows a glossary and adds the labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page. This update does not modify study details, eligibility criteria, outcomes, or user-facing functionality.SummaryDifference0.0%

- Check56 days agoChange DetectedFooter metadata updated: Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedNote added that publications are automatically filled from PubMed for this study, and the page revision is updated to v3.3.2. The previous PubMed auto-fill description and v3.2.0 revision text have been removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Malignant Pleural Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page.